Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
US-2025275920-A1 · Sep 4, 2025 · US
This page is not indexed by search engines while we improve data quality.
Muhs Andreas patents
Muhs Andreas is listed as an inventor on 52 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Muhs Andreas |
| Total patents | 52 |
| First publication | Jan 22, 2015 |
| Latest publication | Sep 4, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Method of safe administration of phosphorylated Tau peptide vaccine
US-12324855-B2 · Jun 10, 2025 · US
Liposomes containing phosphorylated tau peptides for inducing sustained immune responses
US-2025144212-A1 · May 8, 2025 · US
Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses
US-2025134973-A1 · May 1, 2025 · US
Vaccine Therapy
US-2024270829-A1 · Aug 15, 2024 · US
Compositions of phosphorylated tau peptides and uses thereof
US-11958889-B2 · Apr 16, 2024 · US
Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
US-2023381108-A1 · Nov 30, 2023 · US
Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses
US-2023338535-A1 · Oct 26, 2023 · US
Heterologous Administration of Tau Vaccines
US-2023257433-A1 · Aug 17, 2023 · US
Method of safe administration of phosphorylated tau peptide vaccine
US-11684576-B2 · Jun 27, 2023 · US
Recent patents
Latest publications not already listed above.
Heterologous administration of tau vaccines
US-11591377-B2 · Feb 28, 2023 · US
Humanized antibody
US-2022227847-A1 · Jul 21, 2022 · US
Anti-tau antibodies and methods of use
US-11352419-B2 · Jun 7, 2022 · US
Humanized antibody
US-2021317197-A1 · Oct 14, 2021 · US
Compositions of phosphorylated tau peptides and uses thereof
US-11124552-B2 · Sep 21, 2021 · US
Anti-tau antibodies and methods of use
US-2021139572-A1 · May 13, 2021 · US
Compositions of phosphorylated tau peptides and uses thereof
US-2020376078-A1 · Dec 3, 2020 · US
Anti-Tau antibodies and methods of use
US-10836817-B2 · Nov 17, 2020 · US
Heterologous administration of tau vaccines
US-2020339643-A1 · Oct 29, 2020 · US
Method of safe administration of phosphorylated tau peptide vaccine
US-2020253873-A1 · Aug 13, 2020 · US
Humanized antibody
US-2020055928-A1 · Feb 20, 2020 · US
Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
US-10500207-B2 · Dec 10, 2019 · US
Anti-tau antibodies and methods of use
US-2019367592-A1 · Dec 5, 2019 · US
Compositions of phosphorylated tau peptides and uses thereof
US-2019119341-A1 · Apr 25, 2019 · US
Humanized antibody igg1
US-2019031746-A1 · Jan 31, 2019 · US
Humanized antibody
US-2018327485-A1 · Nov 15, 2018 · US
Methods of diagnosing tau-protein-associated disease
US-10100104-B2 · Oct 16, 2018 · US
Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau
US-10066010-B2 · Sep 4, 2018 · US
2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
US-9701660-B2 · Jul 11, 2017 · US
Method for preparing liposome-based constructs
US-9687447-B2 · Jun 27, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ac Immune Sa | 52 |
| Genentech Inc | 20 |
| Janssen Pharmaceuticals Inc | 15 |
| Univ Leuven Kath | 9 |
| Muhs Andreas | 7 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P25/28 | 42 |
| C07K16/18 | 35 |
| G01N33/6896 | 27 |
| C07K2317/565 | 27 |
| A61P25/00 | 27 |